重要成果:
1) Lu ZH; Fu HD*; Huang LF; Wang JJ; Wang CY; Mao JH; Estimation of optimal minimum dosage of mycophenolate mofetil in children with various glomerular diseases, International Journal of Clinical and Experimental Medicine, 2018, 11(1): 316-326.
(2) HaiDong Fu; GuLing Qian*; Zhengyang Jiang. Comparison of second-line immunosuppressants for childhood refractory nephrotic syndrome: a systematic review and network meta-analysis. Journal Investigative Medicine, 2017, 65(1): 65-71.
(3) Fu HD; Mao JH*; Xu YP; Gu WZ; Zhu XJ; Liu AM. Clinical features and outcomes of diffuse endocapillary proliferation Henoch-Schönlein Purpura nephritis in children, Clinics, 2016, 71(9): 550-554.
(4) Fu HD; Mao JH*; Huang L; Wang JJ; Gu WZ; Lu Zhihong. Higher pathological grading is associated with unfavorable outcome of Henoch-Schönlein purpura nephritis in children, International Journal of Clinical and Experimental Pathology, 2016, 9(4): 4633-4640.
(5) Huang Lei; Fu Haidong*; Liu Aiming; Repetition and Histological Features of Renal Biopsies in Childhood Henoch-Schonlein Purpura Nephritis: Report on Eleven Cases, International Journal of Clinical and Experimental Medicine, 2015, 5(5): 426-429.
(6) Hui Xu, Yanxiang Pan, Wei Li, Haidong Fu, Junfeng Zhang, Hongqiang Shen, Xiucui Han.Association between IL17A and IL17F polymorphisms and risk of Henoch–Schonlein purpura in Chinese children. Rheumatol Int .2016,36:829–835